Picture of DIAGNOSTIC MEDICAL SYSTEMS SA logo

ALDMS — DIAGNOSTIC MEDICAL SYSTEMS SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: DMS Group FY Net Loss Widens To 6.8 Mln Euros

April 28 (Reuters) - Diagnostic Medical Systems SA
 ALDMS.PA :
    * 2022 ANNUAL RESULTS
    * FY NET LOSS GROUP SHARE EUR 6.8 MILLION VERSUS LOSS EUR
3.9
MILLION YEAR AGO
    * RESTATED EBITDA: €2.5M - RESTATED EBITDA MARGIN OF 7.0%
(VERSUS.
4.2% IN 2021)
    * FY REVENUE EUR 35.3 MILLION VERSUS EUR 36.3 MILLION YEAR
AGO
    * €4.4 MILLION IN AVAILABLE CASH AT THE END OF 2022
    * CONFIRMATION OF 2023 OBJECTIVES
    * CONFIRMS THE IMPROVEMENT IN ITS PROFITABILITY IN 2023,
WITH AN
EXPECTED INCREASE OF ITS EBITDA MARGIN
    * IN 2027, ON THE HORIZON OF THE IMAGING 2027 PLAN, DMS
GROUP HAS
SET ITSELF OBJECTIVES OF ACHIEVING A TURNOVER OF AT LEAST EUR 60
MILLION AND AN EBITDA MARGIN OF 14%
    * CONFIRMS ITS OBJECTIVE OF CONSOLIDATED REVENUE OF €40
MILLION

Source text for Eikon:  ID:nACT79607 
Further company coverage:  ALDMS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on DIAGNOSTIC MEDICAL SYSTEMS SA

See all news